Novartis India

Market Cap: Small Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE234A01025
NSEID: NOVARTIND
BSEID: 500672

INR

788.00

6.05 (0.77%)

BSENSE

Apr 11, 12:52 PM

BSE+NSE Vol: 14.33 k

{
  "main_header": {
    "sid": 333626,
    "name": "Novartis India",
    "stock_name": "Novartis India",
    "full_name": "Novartis India Ltd",
    "name_url": "stocks-analysis/novartis-india",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "788.00",
    "chg": 6.05,
    "chgp": "0.77%",
    "dir": 1,
    "prev_price": "781.95",
    "mcapval": "1,957.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 500672,
    "symbol": "NOVARTIND",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE234A01025",
    "curr_date": "Apr 11, 12:52 PM",
    "curr_time": "01:27 AM",
    "bse_nse_vol": "14.33 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/novartis-india-333626-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Novartis India Faces Bearish Technical Trends Amid Market Evaluation Revision",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-indias-technical-trend-shifts-from-mildly-bearish-to-bearish-amid-stock-price-decline-1598170",
        "imagepath": "",
        "date": "2025-03-26 08:01:07",
        "description": "Novartis India, a small-cap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 830.00, slightly down from the previous close of 833.15. Over the past year, Novartis India has faced challenges, with a return of -19.63%, contrasting with a 7.12% gain in the Sensex during the same period.\n\nThe technical summary indicates a bearish sentiment in various indicators. The MACD shows a bearish trend on a weekly basis, while the monthly perspective is mildly bearish. Similarly, Bollinger Bands and KST also reflect bearish tendencies, suggesting a cautious outlook. The moving averages on a daily basis align with this sentiment, indicating a prevailing bearish trend.\n\nDespite these challenges, Novartis India has shown resilience over longer periods, with a notable return of 36.18% over three years, closely ..."
      },
      {
        "title": "Novartis India Faces Technical Trend Challenges Amid Market Evaluation Revision",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-indias-technical-trend-shifts-from-bearish-to-mildly-bearish-amid-stock-price-increase-1572747",
        "imagepath": "",
        "date": "2025-03-24 08:00:33",
        "description": "Novartis India, a small-cap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 842.00, showing a notable increase from the previous close of 788.45. Over the past week, the stock has demonstrated a return of 9.48%, outperforming the Sensex, which returned 4.17% in the same period.\n\nIn terms of technical indicators, the MACD reflects a bearish stance on a weekly basis, while the monthly view is mildly bearish. The Relative Strength Index (RSI) shows no significant signals for both weekly and monthly assessments. Bollinger Bands and moving averages also indicate a mildly bearish trend, suggesting a cautious market sentiment. The KST and Dow Theory metrics align with this outlook, indicating a lack of strong upward momentum.\n\nWhen examining the company's performance over various time frames, it has..."
      },
      {
        "title": "Novartis India Outperforms Sector Amid Broader Market Rebound and Small-Cap Gains",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-india-stock-rises-8-95-outperforming-sector-amid-market-rebound-1555314",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/NovartisIndia_priceRelatedfactors_768487.png",
        "date": "2025-03-21 15:30:21",
        "description": "Novartis India has experienced notable stock performance, rising significantly and outperforming its sector. The stock has shown consecutive gains over four days and reached an intraday high. Despite recent gains, its long-term performance reflects a decline compared to broader market trends, including the Sensex."
      },
      {
        "title": "Novartis India Hits 52-Week Low Amid Broader Market Gains and Caution from Investors",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-india-hits-52-week-low-amid-broader-market-gains-stock-declines-7-3-1430415",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/NovartisIndia_priceRelatedfactors_697260.png",
        "date": "2025-03-18 14:35:21",
        "description": "Novartis India has reached a new 52-week low amid a broader market rally, underperforming its sector significantly. Despite a healthy operating profit growth rate and low debt, the stock has seen a decline in profitability and minimal institutional investment, reflecting cautious sentiment among investors."
      },
      {
        "title": "Novartis India Hits 52-Week Low Amid Broader Market Gains and Investor Caution",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-india-hits-52-week-low-amid-continued-stock-decline-and-sector-underperformance-1401270",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/NovartisIndia_priceRelatedfactors_681167.png",
        "date": "2025-03-17 10:36:31",
        "description": "Novartis India has reached a new 52-week low, reflecting a significant decline and underperformance compared to its sector. Despite a slight gain today after five days of losses, the stock remains below key moving averages. Over the past year, it has declined by 21.12%, contrasting with the Sensex's positive trend."
      },
      {
        "title": "Novartis India Faces Market Challenges Amid Declining Stock Performance and Caution from Investors",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-india-stock-hits-52-week-low-amid-ongoing-decline-and-market-weakness-2-1344425",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/NovartisIndia_priceRelatedfactors_665931.png",
        "date": "2025-03-13 12:05:47",
        "description": "Novartis India has reached a new 52-week low, reflecting a downward trend with a notable decline over the past week. The company's one-year performance shows a significant drop, despite strong operating profit growth and a solid cash position. However, its valuation remains high compared to peers, with minimal mutual fund investment."
      },
      {
        "title": "Novartis India Faces Market Challenges Amid Strong Long-Term Growth Potential",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-india-stock-hits-52-week-low-amid-broader-market-volatility-1314131",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/NovartisIndia_priceRelatedfactors_657575.png",
        "date": "2025-03-12 11:06:07",
        "description": "Novartis India is nearing a 52-week low, experiencing a four-day decline and underperforming the broader market with a one-year return of -15.69%. Despite this, the company shows strong long-term growth potential, with significant operating profit growth and solid cash reserves, though its valuation remains high compared to peers."
      },
      {
        "title": "Novartis India Hits 52-Week Low Amidst Declining Stock Performance and Low Mutual Fund Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-india-stock-hits-52-week-low-amid-ongoing-decline-and-market-weakness-1270812",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/NovartisIndia_priceRelatedfactors_637175.png",
        "date": "2025-03-11 09:38:33",
        "description": "Novartis India has reached a new 52-week low, continuing a three-day decline. The stock is trading below key moving averages and has underperformed its sector. Despite a high dividend yield and healthy long-term growth, recent profit declines raise concerns about its near-term performance and market confidence."
      },
      {
        "title": "Novartis India Hits 52-Week Low Amid Ongoing Challenges in Pharmaceuticals Sector",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-india-hits-52-week-low-amid-consecutive-stock-decline-and-underperformance-1176509",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/NovartisIndia_priceRelatedfactors_562813.png",
        "date": "2025-03-03 11:35:23",
        "description": "Novartis India has reached a new 52-week low, continuing a downward trend with a notable decline over the past four days. Despite a brief intraday peak, the stock remains below key moving averages and has underperformed compared to the broader market, reflecting ongoing challenges in the small-cap pharmaceuticals sector."
      }
    ],
    "total": 39,
    "sid": "333626",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/novartis-india-333626"
  },
  "announcements": [
    {
      "caption": "Disclosure Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011.",
      "datetime": "03-Apr-2025",
      "details": "We herewith enclose the declaration required to be disclosed under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations 2011 received from the promoters of the company.",
      "source": "BSE"
    },
    {
      "caption": "Filing Of Intimation Under Regulation 30 For The Receipt Of Draft Tax Assessment Order By The Company",
      "datetime": "27-Mar-2025",
      "details": "Filing of Intimation under Regulation 30 for the receipt of draft tax assessment order by the Company",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "27-Mar-2025",
      "details": "The meeting of the Board of Directors of the Company is scheduled to be held on Friday May 09 2025 to inter alia consider and approve the Audited Financial Results of the Company for the financial year ended March 31 2025 and to recommend dividend on Equity Shares of the Company if any. The trading window for dealing in shares of the Company by all the Designated Persons and their immediate relatives will be closed with effect from Tuesday April 01 2025. The window shall open 48 hours after the said financial results are declared to the Stock Exchange.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "09 May 2025"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Novartis India Ltd has declared <strong>500%</strong> dividend, ex-date: 23 Jul 24",
          "dt": "2024-07-23",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Novartis India Faces Bearish Technical Trends Amid Market Evaluation Revision

2025-03-26 08:01:07

Novartis India, a small-cap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 830.00, slightly down from the previous close of 833.15. Over the past year, Novartis India has faced challenges, with a return of -19.63%, contrasting with a 7.12% gain in the Sensex during the same period. The technical summary indicates a bearish sentiment in various indicators. The MACD shows a bearish trend on a weekly basis, while the monthly perspective is mildly bearish. Similarly, Bollinger Bands and KST also reflect bearish tendencies, suggesting a cautious outlook. The moving averages on a daily basis align with this sentiment, indicating a prevailing bearish trend. Despite these challenges, Novartis India has shown resilience over longer periods, with a notable return of 36.18% over three years, closely ...

Novartis India Faces Technical Trend Challenges Amid Market Evaluation Revision

2025-03-24 08:00:33

Novartis India, a small-cap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 842.00, showing a notable increase from the previous close of 788.45. Over the past week, the stock has demonstrated a return of 9.48%, outperforming the Sensex, which returned 4.17% in the same period. In terms of technical indicators, the MACD reflects a bearish stance on a weekly basis, while the monthly view is mildly bearish. The Relative Strength Index (RSI) shows no significant signals for both weekly and monthly assessments. Bollinger Bands and moving averages also indicate a mildly bearish trend, suggesting a cautious market sentiment. The KST and Dow Theory metrics align with this outlook, indicating a lack of strong upward momentum. When examining the company's performance over various time frames, it has...

Novartis India Outperforms Sector Amid Broader Market Rebound and Small-Cap Gains

2025-03-21 15:30:21

Novartis India has experienced notable stock performance, rising significantly and outperforming its sector. The stock has shown consecutive gains over four days and reached an intraday high. Despite recent gains, its long-term performance reflects a decline compared to broader market trends, including the Sensex.

Novartis India Hits 52-Week Low Amid Broader Market Gains and Caution from Investors

2025-03-18 14:35:21

Novartis India has reached a new 52-week low amid a broader market rally, underperforming its sector significantly. Despite a healthy operating profit growth rate and low debt, the stock has seen a decline in profitability and minimal institutional investment, reflecting cautious sentiment among investors.

Novartis India Hits 52-Week Low Amid Broader Market Gains and Investor Caution

2025-03-17 10:36:31

Novartis India has reached a new 52-week low, reflecting a significant decline and underperformance compared to its sector. Despite a slight gain today after five days of losses, the stock remains below key moving averages. Over the past year, it has declined by 21.12%, contrasting with the Sensex's positive trend.

Novartis India Faces Market Challenges Amid Declining Stock Performance and Caution from Investors

2025-03-13 12:05:47

Novartis India has reached a new 52-week low, reflecting a downward trend with a notable decline over the past week. The company's one-year performance shows a significant drop, despite strong operating profit growth and a solid cash position. However, its valuation remains high compared to peers, with minimal mutual fund investment.

Novartis India Faces Market Challenges Amid Strong Long-Term Growth Potential

2025-03-12 11:06:07

Novartis India is nearing a 52-week low, experiencing a four-day decline and underperforming the broader market with a one-year return of -15.69%. Despite this, the company shows strong long-term growth potential, with significant operating profit growth and solid cash reserves, though its valuation remains high compared to peers.

Novartis India Hits 52-Week Low Amidst Declining Stock Performance and Low Mutual Fund Interest

2025-03-11 09:38:33

Novartis India has reached a new 52-week low, continuing a three-day decline. The stock is trading below key moving averages and has underperformed its sector. Despite a high dividend yield and healthy long-term growth, recent profit declines raise concerns about its near-term performance and market confidence.

Novartis India Hits 52-Week Low Amid Ongoing Challenges in Pharmaceuticals Sector

2025-03-03 11:35:23

Novartis India has reached a new 52-week low, continuing a downward trend with a notable decline over the past four days. Despite a brief intraday peak, the stock remains below key moving averages and has underperformed compared to the broader market, reflecting ongoing challenges in the small-cap pharmaceuticals sector.

View All News

Announcement

Disclosure Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011.

03-Apr-2025 | Source : BSE

We herewith enclose the declaration required to be disclosed under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations 2011 received from the promoters of the company.

Filing Of Intimation Under Regulation 30 For The Receipt Of Draft Tax Assessment Order By The Company

27-Mar-2025 | Source : BSE

Filing of Intimation under Regulation 30 for the receipt of draft tax assessment order by the Company

Closure of Trading Window

27-Mar-2025 | Source : BSE

The meeting of the Board of Directors of the Company is scheduled to be held on Friday May 09 2025 to inter alia consider and approve the Audited Financial Results of the Company for the financial year ended March 31 2025 and to recommend dividend on Equity Shares of the Company if any. The trading window for dealing in shares of the Company by all the Designated Persons and their immediate relatives will be closed with effect from Tuesday April 01 2025. The window shall open 48 hours after the said financial results are declared to the Stock Exchange.